Guangxi Wuzhou Zhongheng Group Co.,Ltd
SHH: 600252.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hai Run Wang
- Employees
- 2,886
- Headquarters
- Wuzhou, China
- IPO year
- 2000
- Market cap
- CN¥7.7B
- Website
- https://www.wz-zhongheng.com
Loading 600252…
Loading profile data…Frequently asked questions about 600252
What does Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252.SS) do?
Guangxi Wuzhou Zhongheng Group Co., Ltd. researches, develops, manufactures, and sells pharmaceuticals in China. The company offers pills, capsules, and injections and tablets for cardiovascular and cerebrovascular diseases, bruises, gynecological diseases, and respiratory diseases. It also produces health food products under the DOUBLE MONEY br...
Where does 600252.SS trade?
Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252.SS) trades on the Shanghai Stock Exchange.
What sector is 600252.SS in?
Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Guangxi Wuzhou Zhongheng Group Co.,Ltd?
Hai Run Wang is the chief executive officer of Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252.SS).
Where is Guangxi Wuzhou Zhongheng Group Co.,Ltd headquartered?
Guangxi Wuzhou Zhongheng Group Co.,Ltd is headquartered in China.
Does 600252.SS pay a dividend?
Yes — Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252.SS) paid a trailing twelve-month dividend of CNY 0.01 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600252.SS go public?
Guangxi Wuzhou Zhongheng Group Co.,Ltd (600252.SS) completed its initial public offering in 2000.